Home Blog Page 2633

Huawei Cloud Propels Singapore Enterprises from Cloud Adoption to Intelligent Leap, Forging Industry Pioneers

SINGAPORE, July 17, 2025 /PRNewswire/ — The Huawei Cloud Singapore Summit 2025, themed “Accelerate Intelligence, Ignite Smarter Future,” brought together over 500 representatives from government, business, and technology sectors today. Attendees discussed how moving from basic cloud adoption to full-scale intelligence can significantly enhance enterprise productivity, enabling businesses to thrive in today’s complex and dynamic environment.

In a world of growing uncertainties, digitalization remains the most effective way to address challenges. Sunny Shang, President of Huawei Cloud Asia Pacific, highlighted Singapore’s crucial role as a global innovation hub, particularly in the intelligent era. Singapore is home to Huawei Cloud’s unique five local Available Zones (AZ) deployment, which delivers the highest possible level of service continuity. On the journey of intelligence and transformation with partners, Huawei acts as a bridge for innovative solutions and industry expertise exchange between Singapore and the rest of the world.

Sunny Shang,  President of Huawei Cloud APAC
Sunny Shang, President of Huawei Cloud APAC

Maxi Wang, CEO of Huawei International, stated “In the era of intelligence, Singapore has always valued practical innovation, the kind that lifts productivity, streamlines operations, and empowers every individual to grow. At Huawei, we see it the same way. We are here to bring global best practices to help Singapore enterprises scale, modernize, and go beyond boundaries with our cloud. We are equally focused on people. We will continue working with our industry and higher education partners to equip the local workforce with globally competitive skills, helping them stay relevant across both East and West in a fast-changing world.”

Maxi Wang, Chief Executive Officer, Huawei International Pte Ltd (Singapore)
Maxi Wang, Chief Executive Officer, Huawei International Pte Ltd (Singapore)

Deepening Technology Roots in Industry Practices

Over the years, Huawei Cloud’s engineers and PhDs have been working directly at customer sites, testing devices in coal mines, monitoring blast furnace parameters in steel mills, and observing outpatient diagnosis and treatment processes in hospitals. This hands-on experience has provided valuable insights, which are then integrated into customer business scenarios to boost production efficiency.

Gigi Hu, Managing Director of Huawei Cloud Singapore, outlined how Huawei Cloud will continuously provide professional services to key industries in Singapore, including the public sector, fintech, internet companies, and large enterprises. First, strategic resources will be invested in consulting, planning, solution design, delivery, service, and R&D support. The goal is to assist 10 major enterprises in implementing multi-cloud strategies, enhancing business resilience, and achieving cloud neutrality. Second, Huawei Cloud’s practices from China and its global operations, alongside industry partnerships, will support more than 50 Singaporean companies upgrade from cloud adoption to intelligent transformation. Third, Huawei Cloud is working with over 100 high-quality partners worldwide to serve the Singapore market and support local partners in expanding their international presence.

Gigi Hu, Managing Director of Huawei Cloud Singapore
Gigi Hu, Managing Director of Huawei Cloud Singapore

At industry workshops held during the summit, Huawei Cloud and its ecosystem partners showcased a wealth of industry practices across sectors. In collaboration with public sectors, Huawei Cloud leverages cloud and intelligent technologies to transform government services, enhancing administrative efficiency and fostering the implementation of people-centric innovative services in Singapore. Internet companies like Grab and Minimax discussed cloud native innovations in areas such as e-commerce scalability and global entertainment acceleration. In FinTech, Huawei Cloud, Criat, DolphinDB, and Cobo shared cutting-edge trends and best practices in credit risk management, intelligent data analysis, and digital asset hosting. For large enterprises aiming to drive digital transformation through a multi-cloud strategy, Huawei is partnering with Kingdee and Transwarp to optimize production processes and intelligent marketing, accelerating service innovation at scale.

Where Technology Innovation Meets Business Needs

Intelligence is now an established trend and a core driver for enterprise innovation and growth. While many customers have embraced cloud, the proliferation of SaaS tools has often led to data silos. The key challenge in the intelligent era is how to more effectively leverage the data accumulated on the cloud.

Aka Dai, Director of Huawei Cloud Marketing, introduced Huawei Cloud’s full-stack innovation for the intelligent era, offering one-stop service capabilities that enable customers to fully utilize data and intelligence in the cloud. This encompasses several critical aspects. First, the integration of data and intelligence helps customers use data more wisely. For example, Huawei Cloud’s data engineering service and KooSearch Retrieval-Augmented Generation (RAG) solution enable enterprises to fully unleash the potential of their data. Second, Huawei Cloud infuses intelligence across business functions—including R&D, production, supply, and sales—helping organizations turn innovative ideas into tangible results through Huawei Cloud’s cloud services and toolchains. At the application innovation level, Huawei Cloud provides CodeArts, a one-stop DevSecOps platform. This platform supports the entire lifecycle of software development and incorporates AI features. For example, CodeArts Doer for Coding can autonomously generate, explain, check, and comment on code, significantly boosting software development efficiency.

Aka Dai, Director of Huawei Cloud Marketing
Aka Dai, Director of Huawei Cloud Marketing

Building an Innovation Powerhouse Together

Singapore plays a vital role bridging East and West. Similarly, Huawei Cloud serves as a global platform powered with an open, versatile ecosystem comprising 500 technology partners and 50 service partners in Singapore.

Huawei Cloud brings new technologies to Singapore and helps Singaporean partners expand globally. For example, Singaporean local partner WIZ.AI has deepened its cooperation with Huawei Cloud, expanding its business into the Philippines, Indonesia, Singapore, Thailand, and Malaysia. China’s leading fintech company, Sunline, has also established a presence in Singapore, with its customer service fully validated in the local market.

Huawei Cloud is also committed to integrating technological innovation in everyday life, nature conservation, and sustainable development. Frank Guo, Managing Director of Huawei International, shared several cases illustrating the tangible impact of the “Cloud for Good” philosophy. Naturally, this effort hinges on digital talent. In Singapore, Huawei is actively promoting the next generation of innovators through initiatives like Tech4City, which encouragesyouth and startups to apply technology for public good. A notable example is SafeGuardSG, an emergency response platform developed by local students which uses AI to improve real-time coordination and community safety. FingerDance, a startup supported by Huawei Cloud’s incubator, has collaborated with SBS Transit and jointly launched the Sign Language Virtual Assistant SiLVia. SiLViA is being trialled at the North East Line Chinatown MRT Station in Singapore, helping hard-of-hearing commuters to travel independently and safely on public transport. PrimePlay, the winner of Huawei Tech4City 2024, combines games and sensing devices to create a more engaging and effective fitness experience for seniors. Moving forward, Huawei Cloud will continue to collaborate with more customers and partners to accelerate Singapore’s digitalization in healthcare, green and low-carbon development, and digital talent cultivation.

Frank Guo, Managing Director for Public Affairs, Huawei International Pte Ltd (Singapore)
Frank Guo, Managing Director for Public Affairs, Huawei International Pte Ltd (Singapore)

The summit also includes exhibition areas where visitors can experience cutting-edge technologies such as digital human and smart magic mirrors, alongside the latest technological advancements in GaussDB, big data, and ModelArts. Leading partners including NXAI, Yonyou, Kingdee, and Freedo, shared their experiences and ideas to foster collaborative innovation.

Cushman & Wakefield: China Leads REIT Market Expansion in Asia while India’s REIT Market Demonstrates Robust Growth

  • Chinese mainland REIT market joined the top three largest REIT markets in Asia for the first time with an 85% increase in market value in 2024
  • India’s office REIT market attracted considerable leasing demand from global capability centres
  • Data centre and hospitality REITs gained strong investor interest in Japan and Singapore

HONG KONG SAR – Media OutReach Newswire – 17 July 2025 – China and India’s Real Estate Investment Trust (REIT) markets showed robust growth in 2024 and are expected to continue to attract strong investor interest this year, according to Cushman & Wakefield’s Asia REIT Market Insight 2024-2025. The annual report revealed that the Chinese mainland REIT (C-REIT) market achieved a remarkable 85% increase in market value at the end of 2024, surpassing Hong Kong and becoming one of the region’s top three REIT markets. In the same period, India’s REIT market demonstrated robust growth in the office sector, driven by strong leasing demand for institutional-grade office space. Meanwhile, mature markets such as Japan, Singapore and Hong Kong moved toward stabilization, underlining their long-term resilience.

Catherine Chen, Director, Investor Client Intelligence & Insights, Asia Pacific at Cushman & Wakefield said, “The unprecedented growth in the C-REIT market highlights its role as a critical driver of regional expansion, while India’s performance emphasizes the growing strength of the country’s institutional-grade real estate. These markets continue to create new and exciting opportunities for investors targeting Asia.”

Cushman & Wakefield’s data showed a total of 263 active REIT products in the Asia market as of December 31, 2024, with a combined market value of US$235.8 billion, reflecting a year-on-year decline of 6.5%. The contraction was primarily driven by declines in the U.S. dollar values of the Japan, Singapore and Hong Kong markets due to the widespread softening in REIT stock prices and unfavorable exchange rate movements. Amid these declines, the Chinese mainland REIT market emerged as a bright spot, posting an impressive 85% year-on-year rise in market value, attributable to new REIT product issuances and strong investor demand for infrastructure-backed assets.

In the mature markets, Japanese REITs experienced significant gains in dividend yield, led by stock price moderation and asset performance improvements, particularly among hotel REITs, which benefited from inbound tourism. In Singapore, positive total returns were observed across multiple property types in 2024, including data centres at 9.7%, and healthcare at 6.9%. Elsewhere in Asia, Thailand demonstrated robust performance with a 41% increase in market value, marking it as the second-highest growth market in the region. The Philippines, Malaysia and India reported increases of 37%, 21% and 13% respectively, supported by their favorable economic fundamentals and attractive real estate sectors.

Total Market Value of Active REITs on Major Asia Exchanges (December 2024)

Market Number of REITs Market Value (USD billion) Market Share (%)
Japan 57 90.8 38.5
Singapore 39 67.4 28.6
Chinese Mainland 58 21.4 9.1
Hong Kong, China 11 16.1 6.8
India 4 11.0 4.6
Thailand 38 8.3 3.5
Malaysia 18 7.7 3.2
The Philippines 8 5.8 2.5
South Korea 24 5.3 2.3
Taiwan, China 6 21.0 0.9
Total 263 235.8 100

Source: Bloomberg database, compiled by Cushman & Wakefield Valuation & Advisory Services

Expansion of C-REIT market

The year 2024 saw a breakthrough in C-REIT issuance with 29 new REIT products, including 19 real estate-backed REITs. This represented the highest annual issuance recorded to date. Among product categories, consumer infrastructure REITs led the issuance count with seven new listings, followed by industrial park REITs with six launches. Heading into 2025, the market has maintained its robust trajectory with six REITs launched in Q1, including five real estate-backed products. As of March 31, 2025, a total of 64 public infrastructure REITs were listed in the Chinese mainland, marking a significant period of growth in the market.

Chris Yang, Senior Director, Head of REITs Practice Group, China, at Cushman & Wakefield said, “The C-REIT market has achieved a historic milestone in 2024, in both market value expansion and new product issuance. This surge reflects both greater investor confidence in infrastructure-backed REITs and the success of new issuances in retail and industrial REITs. Looking ahead, we anticipate further diversification and expansion as regulatory frameworks evolve to attract both domestic and international investors.”

Global capability centres drive leasing demand for India office REITs

India’s office asset REITs have attracted a considerable share of demand from global capability centres (GCCs), which is an important growth driver for India’s office markets. At a Pan-India level, GCCs have accounted for 28%–29% of gross leasing volume on average over the last four quarters up to Q1 2025. In contrast, REIT landlords were able to achieve a much higher share, at 40%–60% of total leasing demand from GCC firms, rendering institutionally owned assets the preferred choice for many multinational occupiers.

Somy Thomas, Executive Managing Director, Valuations and Co- Head, Capital Markets, India at Cushman & Wakefield commented, “India’s REIT market continues to carve a strong trajectory, with exceptional growth seen across the office sector. Multinational companies, especially GCCs have driven record leasing activity, which now accounts for a significant share of the nation’s Grade A office stock. There has also been a growing preference among occupiers for premium grade assets, thereby significantly benefiting REITs. All three office REITs in India achieved occupancy rates close to 90% at the end of Q1 2025.”

A fourth office REIT in India is expected to make its listing debut by the end of the calendar year 2025. With 48 million sq ft of Pan-India Grade A office space (37 million sq ft operational and 11 million sq ft under development), Knowledge Realty Trust, which is backed by Blackstone and Sattva Developers is expected to become one of the largest real estate investment trusts listed in India.

Looking Ahead

The Asia REIT market is poised for continued evolution as it navigates the dual forces of mature market stabilization and emerging market expansion. “We expect the mature markets of Japan, Singapore and Hong Kong to focus on enhancing operational efficiencies while grappling with the challenges posed by global monetary policy shifts. On the other hand, emerging markets, particularly the Chinese mainland, India and Thailand are expected to continue to grow, bolstered by strong economic fundamentals and supportive regulatory frameworks”, noted Catherine Chen.

Cushman & Wakefield’s report also noted that data centre and hospitality REITs are expected to remain highly visible on investors’ radar, driven by AI advancements and recovery in the tourism sector respectively. Additionally, M&A activity is likely to pick up as players seek scale and diversification to better weather market fluctuations.

Please click here to download the report.

Hashtag: #Cushman&Wakefield

The issuer is solely responsible for the content of this announcement.

Cushman & Wakefield

Cushman & Wakefield (NYSE: CWK) is a leading global commercial real estate services firm for property owners and occupiers with approximately 52,000 employees in nearly 400 offices and 60 countries. In Greater China, a network of 23 offices serves local markets across the region. In 2024, the firm reported revenue of $9.4 billion across its core services of Valuation, Consulting, Project & Development Services, Capital Markets, Project & Occupier Services, Industrial & Logistics, Retail, and others. Built around the belief that Better never settles, the firm receives numerous industry and business accolades for its award-winning culture. For additional information, visit or follow us on LinkedIn ().

Salloot Nova P5: Ultra-Compact, High-Performance IPL Hair Removal Device Powered by Mini Tech™

LOS ANGELES, July 17, 2025 /PRNewswire/ — SALLOOT unveils Nova P5—ultra-compact and high-performance mini IPL. With 22J mega power, sapphire ice-cooling, and Super Clean™ Double Pulses, it delivers painless, pro-level results anytime, anywhere.


Mini Tech™—Compact, Powerful, and Travel-Ready: The Future of At-Home IPL

Engineered for ease and performance, Salloot Nova P5 is 102g lighter and 35% smaller than comparable IPL devices—making it easier to hold with reduced hand fatigue. Despite its compact size, it delivers 78W of high power and up to 22J energy output, significantly enhancing light intensity for more efficient hair removal. Its integrated 1500μF 360V capacitor, built into the adapter, ensures greater energy stability and consistent performance with every flash.

Super Clean™ Enables Faster, More Effective Hair Removal

Powered by Super Clean™ Double-Pulse Technology, Salloot Nova P5 delivers 2× focused energy deep into the hair follicle, accelerating results and improving long-term smoothness. Its upgraded IGBT 3.0 flash system enables 120 high-speed flashes per minute, allowing for full-body treatments in just 8–10 minutes. Combined with a rapid 0.9-second flash interval, each session is fast, safe, and highly efficient—perfect for busy lifestyles without compromising performance.

Luxury Sapphire Ice-Cooling for a Painless Experience

Designed with comfort in mind, Nova P5 IPL hair removal features Salloot’s most advanced mini sapphire ice-cooling system, offering up to 2× the comfort of traditional IPL devices.

The Quick Ice Mode cools the treatment surface to 44.6°F (7°C) in just 30 seconds, reaching peak cooling performance in 5 minutes. For longer sessions, Constant Ice Mode maintains a steady 59°F (15°C) for up to 35 minutes of uninterrupted use. A patented U-shaped airflow system keeps cooling stable and consistent, ensuring every session feels soothing. It’s an ideal hair removal for arms and bikini line, which are sensitive areas.

AI Smart App: Your Personal Skincare Beautician at Home

The Nova P5 pairs with an AI-powered Smart App, turning your device into a personal at-home beauty expert. It creates customized treatment plans based on your skin tone, hair color, body profile, and treatment area, while offering real-time progress tracking, AI-generated reports, and timely reminders to keep you on track. With its intuitive, beginner-friendly interface, the app ensures that professional guidance is always within reach—bringing the experience of a virtual beautician right into your home.

Why Choose the Salloot Nova P5

Experience unmatched convenience with the ultra-lightweight Nova P5—35% smaller and 102g lighter, ideal for both travel and everyday use. Powered by Super Clean™ double-pulse technology, it delivers fast and effective treatments at 120 flashes per minute. Enjoy superior comfort thanks to premium sapphire ice-cooling, designed for pain-free sessions. The smart AI-driven app provides personalized guidance to optimize your hair removal journey. Built with advanced UV filtering and skin-brightening optics, the Nova P5 ensures safe, gentle care for all skin types. Nova P5 IPL hair removal costs less compared to laser hair removal, making it a smarter, more accessible choice. Whether you’re beginning your hair removal routine or upgrading to a sleek, portable device, the Nova P5 combines cutting-edge technology with effortless usability.

Availability & Pricing

The Salloot Nova P5 is available now for $109, with a special $140 OFF discount code”PRNEWS140″ for a limited time.

For more information and to discover the power of portable IPL, visit www.sallootbeauty.com.

Official Links

Website: https://bitl.to/4g3M 

Amazon: https://www.amazon.com/dp/B0F5MRTM54?maas=maas_adg_B6B1EE2B1D997910B548148B55704B29_afap_abs&ref_=aa_maas&tag=maas

Organization: SALLOOT

About SALLOOT:

SALLOOT delivers salon-quality home beauty solutions powered by AI and innovative technology—making safe, effective, and convenient treatments accessible to all. Founded by experts with over 10 years of experience in AI robotics and laser beauty, SALLOOT integrates in-house R&D, design, and manufacturing with a team of 50+ professionals. Our mission is to help everyone, including those with sensitive skin or stubborn hair, achieve smooth, hair-free skin at home through advanced IPL, sapphire cooling, and intelligent design. make the home beauty experience more convenient and comfortable for all.

Lifezoom Launches Veyra Series: Flexible Red Light Therapy Panels That Redefine Home Wellness

NEW YORK, July 17, 2025 /PRNewswire/ — Lifezoom, a pioneer of red light therapy in the USA, is excited to expand with the new industry-leading Veyra Series, red light therapy panels that mix creativity, adaptability, and health-focused design. Now, with two launch products, Veyra C and Veyra S, this versatile red light technology, built on a flexible silicone base material, is available throughout the U.S and Europe at the starting price of $249.

With proper mounting accessories, Lifezoom’s Veyra series red‑light devices can be deployed in various settings, and their unique materials and design allow them to function either as panel lamps or as wearable belts.
With proper mounting accessories, Lifezoom’s Veyra series red‑light devices can be deployed in various settings, and their unique materials and design allow them to function either as panel lamps or as wearable belts.

After years of research and development, the Lifezoom engineering team from Iowa’s hardworking community has brought to market a product that not only eases chronic pain and fatigue but also reimagines the way people receive light therapy in the home or office. Built for the real-life conditions and the various needs of users, the Veyra Series redefines the limits of traditional belt and panel-type red light devices through its flexible form, targeted performance.

Efficacy Guarantee: Technology That Delivers
96 Dual-Chip LEDs: The Veyra series device is made up of 96 advanced LEDs in dual chips – 660nm Red, 850nm Near infrared. This frequency pairing travels from skin to deep tissue, helping with everything from collagen regeneration and joint recovery.[1]  

Unique Lens Design: Each LED has a 30° high-transmittance optical lens, improving focus to guarantee therapeutic and dermatological safe intensity upon skin contact. While many home-use devices scatter light like a soft glow, Veyra concentrates it — like a just-magnified sunbeam — to precisely target your problem areas.

Flexible Panel Material: Lifezoom’s Veyra device uses an elastic, adjustable panel material that can be bent into an arc to provide wrap-around irradiation for affected areas such as the face and wrist. Combined with the included straps, it achieves targeted therapeutic effects similar to traditional belts.

A Dual Purpose Innovation: Belt or Panel — You Choose

Veyra C —  it’s all about the desk. It’s designed to be fixed to the edge of a desk, ideal for those who work long hours at a desk. The device helps relieve discomfort caused by desk work. It can irradiate the head at a high angle to ease nerve tension or be positioned inverted in an arc shape to treat conditions like tenosynovitis and “mouse hand” from multiple angles. Within arm’s reach at the desk can be a cold cup of coffee or a healing red light lamp.

Veyra S — With its base placed on the floor, the adjustable arm allows the panel to shine from above, providing top-down irradiation. This model is designed for use on a recliner or bed, especially suitable for those with limited mobility. The floor base lies flat, without protruding wheels or hard parts. Lifezoom’s purpose is to soothe your fatigue and, just as importantly, prevent your toes from accidental injury.

Effortless Setup and Daily Use
The Veyra Series is designed for ease.

Setup time: 2 minutes for setup, 1 minute to learn the rules

Position modification: The device is easy to install, and angle adjustments are made by simply pressing and releasing buttons on the joints, requiring no tools—your toolbox can stay neatly put away. Find your most comfortable lying position in 11 seconds, adjust your pillow in 5 seconds, and start the device in only 2 seconds.

Operation memory: The built-in memory stores the last used power and time settings. Launch your session with a single touch. Whether it be a four-times-a-week, 30-minute health boost or a six-times-a-week, 40-minute treatment regimen, the device’s power levels and session durations (20W, 30W, 40W; 10-90 minutes) can be easily changed via the included controller.

Science-Backed Results, Everyday Relief

The Veyra Series is based on extensive studies in photobiomodulation therapy (PBMT). Research studies demonstrate that red and NIR light can:

  • Relieve joint pain and inflammation
  • Improve muscle recovery and circulation
  • Boost cellular energy production
  • Promote hair re-growth and collagen production
  • Enhance the quality of sleep and testosterone levels [2] [3]

From Clinics to Living Room

Once limited to clinics and sports recovery centers, red light therapy is now in reach at home with the Veyra Series. In a quiet, compact design, Lifezoom delivers the therapeutic-grade power you need — no appointments, no noise, just care when and where you need it the most.

Whether you’re a sports enthusiast recovering from a strain or an office worker with tech neck, or a guardian taking care of a loved one with limited mobility, the Veyra Series has got you covered.

Design for Safety and Comfort

Design Safety: Veyra uses a unique convex lens design that enhances treatment effectiveness while improving heat dissipation efficiency.

Silent design: Thanks to this highly efficient heat dissipation, no fans are needed to eliminate operating noise or to avoid adverse skin reactions caused by heat during close contact use.

Material Safety: The silicone curved lamp surface uses food-grade silicone, which effectively prevents mold and moisture, greatly extending product life and making it easy to clean with a small brush. Its environmentally friendly properties are harmless, and its non-toxic nature means it can safely coexist in a room with babies and pets. Lifezoom can’t prevent your little one’s curiosity from enjoying “taste tests” with new things they experience with their teeth. Even if your toddler decides to “taste-test” it, Lifezoom ensures it is non-toxic and worry-free.

Warranty, Service, & Availability

Availability: Veyra C and Veyra S are now available at the Lifezoom official website  and the Lifezoom store on Amazon, and authorized dealers in the U.S. and Europe. With the starting price as $249

Each of Veyra Series products is covered by the regular one-year warranty, extendable to two years with registration within 14 days of purchase. For support, users can reach us at official mailbox or register directly at the warranty page of Lifezoom

About Lifezoom
Not content with being just another lamp, Veyra is crafted to be a quiet, reliable companion in your everyday life. At Lifezoom, we’re constantly exploring how to refine the behavior of light so our products adapt to your lifestyle—not the other way around. With its soft, malleable form and intuitive, non‑invasive design, Veyra seamlessly fits into your schedule, delivering therapy without the fuss of specs or the rigidity of tradition. We don’t chase parameter-stacking; we dig deep into real user needs and push the boundaries of what light can do. This very spirit is the driving force behind Lifezoom’s innovation today. Our story is far from over—and this time, we’re letting the light do the talking.

Media Contact: Joey, marketing@lifezoom.tech

References

[1] Cleveland Clinic. “Red Light Therapy: Benefits, Side Effects & Uses.” Cleveland Clinic, 1 Dec. 2021, my.clevelandclinic.org/health/articles/22114-red-light-therapy.
[2] “What Is RLT?” WebMD,
www.webmd.com/skin-problems-and-treatments/red-light-therapy
[3] de Almeida P, Lopes-Martins RA, De Marchi T, et al. Red (660 nm) and infrared (830 nm) low-level laser therapy in skeletal muscle fatigue in humans: what is better?. Lasers Med Sci. 2012;27(2):453-458. doi:10.1007/s10103-011-0957-3

 

Co-PSMA trial: Recruitment successfully completed

SYDNEY, July 17, 2025 /PRNewswire/ — Clarity Pharmaceuticals (ASX: CU6) (“Clarity” or “Company”), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that the Co-PSMA (NCT06907641)[1] Investigator-Initiated Trial (IIT) led by Prof Louise Emmett at St Vincent’s Hospital Sydney has now completed study enrolment, with all participants having been imaged.

The study is evaluating the performance of Clarity’s diagnostic product, 64Cu-SAR-bisPSMA, in comparison to standard-of-care (SOC) 68Ga-PSMA-11 for the detection of prostate cancer recurrence in patients with low prostate-specific antigen (PSA) who are candidates for curative salvage therapy.

Co-PSMA (Comparative performance of 64Copper [64Cu]-SAR-bisPSMA vs. 68Ga-PSMA-11 PET CT for the detection of prostate cancer recurrence in the setting of biochemical failure following radical prostatectomy) is a prospective, Phase II imaging trial in 50 patients in biochemical recurrence (BCR) of prostate cancer. Eligible patients were required to have had radical prostatectomy with no salvage therapy and a PSA between 0.2 and 0.75 ng/mL. The primary objective of the trial is to compare the detection rate of sites of prostate cancer recurrence, as determined by number of lesions per patient, between 64Cu-SAR-bisPSMA and 68Ga-PSMA-11 PET/CT.

The diagnostic capabilities of 64Cu-SAR-bisPSMA compared to SOC diagnostic imaging have been demonstrated in two prospective clinical trials, PROPELLER[2] and COBRA[3]. Following the positive results of these trials, Clarity is conducting two Phase III registrational trials, CLARIFY[4] and AMPLIFY[5], in the pre-prostatectomy and BCR settings, respectively. The CLARIFY trial is recruiting patients at St Vincent’s Hospital Sydney and this site will also open recruitment for the AMPLIFY trial shortly with Prof Emmett as the principal investigator.

Dr Alan Taylor, Executive Chairperson of Clarity Pharmaceuticals, commented: “We are excited about this important milestone in the Co-PSMA trial and the development program of 64Cu-SAR-bisPSMA. With mounting data of the benefits that 64Cu-SAR-bisPSMA could offer compared to SOC diagnostic imaging, demonstrated in the PROPELLER and COBRA trials, we eagerly anticipate the results from this head-to-head trial against 68Ga-PSMA-11.

“The high volume of patients imaged in recent months at a single site reflects the high unmet need for more effective diagnostic tools for men with rising PSA following radical prostatectomy. Visualising cancer early in these patients is crucial for physicians to determine the optimal course of treatment before the cancer spreads, leading to improved outcomes, including the potential for cure. We are very pleased to be able to support Prof Emmett, a world-renowned thought leader in the theranostics space, through the Co-PSMA trial in our own city of Sydney. We are honoured to continue working together on our pipeline of Targeted Copper Theranostics (TCTs) at St Vincents Hospital Sydney, as it is already actively recruiting patients for the CLARIFY trial and preparing to open enrolment for the AMPLIFY trial shortly.”

Prof Louise Emmett (St Vincent’s Hospital Sydney), Principal Investigator in the Co-PSMA trial, commented, “We are pleased to have reached our enrolment target for the Co-PSMA trial. Imaging prostate cancer patients has evolved significantly in recent years, particularly with the development of the current-generation PSMA targeted products. The approved PSMA PET products have high specificity, however, due to their low sensitivity, especially in patients with low PSA, a considerable proportion of patients have no detectable disease on the scans while their PSA continues to rise, indicating recurrence of their cancer. With no clear visualisation of where the cancer is located, planning effective treatments is challenging. Early intervention is essential in order to achieve cure in BCR, and the need for more sensitive diagnostics remains. This unmet need is what led us to design the Co-PSMA study.

“The data generated thus far on 64Cu-SAR-bisPSMA in the PROPELLER and COBRA trials are very encouraging. The high lesion uptake and retention of the product over time provides better visualisation on same-day imaging compared to SOC imaging. Furthermore, the delayed imaging, enabled by the longer half-life of copper-64 compared to gallium-68 and fluorine-18, increases image contrast, helping to identify smaller lesions and allowing more flexible scheduling of patients. If the Co-PSMA trial confirms that 64Cu-SAR-bisPSMA can detect more lesions than 68Ga-PSMA-11 in this patient group with such low PSA, this may improve image-guided therapy, potentially avoiding complications and improving outcomes. We look forward to reporting the trial results in the coming months.”

About SAR-bisPSMA

SAR-bisPSMA derives its name from the word “bis”, which reflects a novel approach of connecting two PSMA-targeting agents to Clarity’s proprietary sarcophagine (SAR) technology that securely holds copper isotopes inside a cage-like structure, called a chelator. Unlike other commercially available chelators, the SAR technology prevents copper leakage into the body. SAR-bisPSMA is a Targeted Copper Theranostic (TCT) that can be used with isotopes of copper-64 (Cu-64 or 64Cu) for imaging and copper-67 (Cu-67 or 67Cu) for therapy.

Disclaimer

64Cu-SAR-bisPSMA is an unregistered product. The safety and efficacy of 64Cu-SAR-bisPSMA has not been assessed by health authorities such as the US Food and Drug Administration (FDA) or the Therapeutic Goods Administration (TGA). There is no guarantee that this product will become commercially available.

About Prostate Cancer

Prostate cancer is the second most common cancer diagnosed in men globally and the fifth leading cause of cancer death in men worldwide[6]. Prostate cancer is the second-leading causes of cancer death in American men. The American Cancer Institute estimates in 2025 there will be about 313,780 new cases of prostate cancer in the US and around 35,770 deaths from the disease[7].

For more information, please contact:

Clarity Pharmaceuticals

Dr Alan Taylor

Lisa Sadetskaya

Executive Chairperson

Director, Corporate Communications

ataylor@claritypharm.com 

lisa@claritypharm.com 

References

1.  ClinicalTrials.gov Identifier: NCT06907641, https://clinicaltrials.gov/study/NCT06907641

2.  Eva Lengyelova et al. 64Cu-SAR-bisPSMA (PROPELLER) positron emission tomography (PET) imaging in patients with confirmed prostate cancer. JCO 41, 5039-5039(2023). DOI:10.1200/JCO.2023.41.16_suppl.5039

3.  Clarity Pharmaceuticals, https://www.claritypharmaceuticals.com/news/cobra_additional_results/

4.  ClinicalTrials.gov Identifier: NCT06056830, https://clinicaltrials.gov/ct2/show/NCT06056830

5.  ClinicalTrials.gov Identifier: NCT06970847, https://clinicaltrials.gov/study/NCT06970847

6.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries, https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.21660 

7.  American Cancer Society: Key Statistics for Prostate Cancer, https://www.cancer.org/cancer/prostate-cancer/about/key-statistics.html

This announcement has been authorised for release by the Executive Chairperson.

Synopsys Completes Acquisition of Ansys

Creating the Leader in Engineering Solutions from Silicon to Systems

News Highlights:

  • Combines leaders in silicon design, IP and simulation and analysis to enable customers to rapidly innovate AI-powered products 
  • Now positioned to win in an expanded $31 billion total addressable market (TAM)1
  • Fast-tracking integrated technology roadmap, with first set of combined capabilities planned for the first half of 2026

SUNNYVALE, Calif., July 17, 2025 /PRNewswire/ — Synopsys (Nasdaq: SNPS) today announced the completion of its acquisition of Ansys. The transaction, which was announced on January 16, 2024, combines leaders in silicon design, IP and simulation and analysis to enable customers to rapidly innovate AI-powered products. Synopsys is now positioned to win in an expanded $31 billion total addressable market (TAM).1

Synopsys Completes Acquisition of Ansys
Synopsys Completes Acquisition of Ansys

“Today marks a transformational milestone for Synopsys. For decades, Synopsys has been delivering breakthroughs in silicon design and IP that have fueled chip innovation,” said president and CEO of Synopsys, Sassine Ghazi. “The increasing complexity of developing intelligent systems demands design solutions with a deeper integration of electronics and physics, enhanced by AI. With Ansys’ leading system simulation and analysis solutions now part of Synopsys, we can maximize the capabilities of engineering teams broadly, igniting their innovation from silicon to systems.”

Former Ansys president, CEO, and board member Ajei Gopal and former Ansys board member Ravi Vijayaraghavan are joining Synopsys’ board of directors, effective immediately.

“For half a century, Ansys has enabled innovators across industries to push boundaries with the predictive power of simulation and analysis,” said Gopal. “Our companies have a common culture, a successful longstanding partnership, and now a united mission to empower innovators to drive human advancement. I look forward to serving this mission as a member of the Synopsys board and expect a swift, successful integration.”

Synopsys remains dedicated to helping engineers innovate, reduce time-to-market and costs, and improve product quality by delivering unprecedented insights into how their products will perform in the real world. And, united with Ansys, Synopsys can now deliver holistic system design solutions for customers in industries spanning semiconductors, high-tech, automotive, aerospace, industrial, and more.

Synopsys expects to deliver the first set of integrated capabilities in the first half of 2026 that fuse multiphysics across the full EDA stack, including for multi-die advanced packaging. The combined roadmap also includes integrated solutions to advance testing and virtualization of complex, intelligent systems for automotive and other industries.

This combination bolsters Synopsys’ strong financial position with projected margin expansion and greater unlevered free cash flow generation, enabling rapid deleveraging over a period of two years. Ansys common stock will no longer be listed for trading on the NASDAQ stock market.

Other Resources

1

2023 TAM based on Synopsys management estimates

About Synopsys
Synopsys, Inc. (Nasdaq: SNPS) is the leader in engineering solutions from silicon to systems, enabling customers to rapidly innovate AI-powered products. We deliver industry-leading silicon design, IP, simulation and analysis solutions, and design services. We partner closely with our customers across a wide range of industries to maximize their R&D capability and productivity, powering innovation today that ignites the ingenuity of tomorrow. Learn more at www.synopsys.com

© 2025 Synopsys, Inc. All rights reserved. Synopsys, the Synopsys logo, and other Synopsys trademarks are available at https://www.synopsys.com/company/legal/trademarks-brands.html . Other company or product names may be trademarks of their respective owners.

Forward Looking Statements

This press release includes certain forward-looking statements within the meaning of the federal securities laws, including, but not limited to, statements that relate to our expected future business and financial performance, the anticipated benefits of the transaction, the anticipated impact of the transaction on the combined business, and the expected synergies from the transaction. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions or the negatives of these words or other comparable terminology to convey uncertainty of future events or outcomes. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks, uncertainties and other factors that could cause actual future events to differ materially from the forward-looking statements in this communication, including, but not limited to: (i) our ability to maintain relationships with Synopsys’ and Ansys’ customers, suppliers and other business partners; (ii) the effect of the transaction on our operating results and business; (iii) our ability to implement plans, forecasts, expected financial performance and other expectations with respect to the combined business and realize the expected benefits/synergies as well as manage the scope and size of the combined company; (iv) unexpected costs, charges and expenses related to the integration; (v) our ability to successfully integrate Ansys’ operations and product lines; (vi) difficulties in retaining and hiring key personnel and employees due to the integration; (vii) the diversion of management time on integration; (viii) our ability to manage significant indebtedness, including indebtedness incurred in connection with the transaction, and the need to generate sufficient cash flows to service and repay such debt; (ix) uncertainty in the macroeconomic and geopolitical environment and its potential impact on the semiconductor and electronics industries; (x) uncertainty in the growth of the semiconductor, electronics and artificial intelligence industries, (xi) the highly competitive industries we operate in; (xii) actions by the U.S. or foreign governments, such as the assessment of fines or the imposition of additional export restrictions or tariffs; (xiii) consolidation among our customers and within the industries in which we operate, as well as our dependence on a relatively small number of large customers; and (xiv) the evolving legal, regulatory and tax regimes under which we operate. 

Our filings with the Securities and Exchange Commission, which you may obtain for free at its website at http://www.sec.gov, discuss some of the important risk factors that may affect our business, results of operations and financial condition. Actual results may vary from the estimates provided. We undertake no intent or obligation to publicly update or revise any of the estimates and other forward-looking statements made in this announcement, whether as a result of new information, future events or otherwise, except as required by law.

Investor Contact:
Trey Campbell
Synopsys, Inc.
650-584-4289
Synopsys-ir@synopsys.com 

Editorial Contact
Cara Walker 
Synopsys, Inc. 
(650) 584-5000
corp-pr@synopsys.com

Synopsys
Synopsys

 

High-Trend International Group Held Extraordinary General Meeting for Share Capital Restructure

SINGAPORE, July 17, 2025 /PRNewswire/ — High-Trend International Group (the “Registrant” or the “Company”) (NASDAQ: HTCO), a global ocean technology company, held its Extraordinary General Meeting of Shareholders (the “Meeting”) on July 16, 2025. At the Meeting, the shareholders voted to approve (1) the proposal that effective immediately following the close of the Meeting, every 25 issued and unissued class A ordinary shares of a par value of US$0.0001 each and every 25 issued and unissued class B ordinary shares of a par value of US$0.0001 each in the Company’s existing share capital be consolidated into 1 class A ordinary share of a par value of US$0.0025 and 1 class B ordinary share of a par value of US$0.0025, respectively (each a “Consolidated Share”) and such Consolidated Shares shall rank pari passu in all respects with each other and have the rights and privileges and be subject to the restrictions as contained in the third amended and restated memorandum and articles of association of the Company (the “Share Consolidation”), so that immediately following the Share Consolidation, the authorized share capital of the Company shall be changed from US$50,000 divided into 497,500,000 class A ordinary shares of a par value of US$0.0001 each and 2,500,000 class B ordinary shares of a par value of US$0.0001 each, to US$50,000 divided into 19,900,000 class A ordinary shares of a par value of US$0.0025 each and 100,000 class B ordinary shares of a par value of US$0.0025 each; (2) the proposal that effective immediately following the close of the Meeting, the authorized share capital of the Company be increased by the creation of an additional 470,000,000 class A ordinary shares of a par value of US$0.0025 each and 10,000,000 class B ordinary shares of a par value of US$0.0025 each to rank pari passu in all respects with the existing class A ordinary shares and class B ordinary shares, respectively (the “Increase of Authorized Share Capital”) so that immediately following the Increase of Authorized Share Capital, the authorized share capital of the Company shall be changed from US$50,000 divided into 19,900,000 class A ordinary shares of a par value of US$0.0025 each and 100,000 class B ordinary shares of a par value of US$0.0025 each, to US$1,250,000 divided into 489,900,000 class A ordinary shares of a par value of US$0.0025 each and 10,100,000 class B ordinary shares of a par value of US$0.0025 each; and (3) the proposal that effective immediately following the close of the Meeting, the second amended and restated memorandum and articles of association of the Company currently in effect be amended and restated by the deletion in their entirety and the substitution in their place of the third amended and restated memorandum and articles of association annexed to the notice of the Meeting.

About High-Trend International Group

High-Trend International Group (“High-Trend” or the “Company”) is a global ocean technology company with businesses in international shipping and marine carbon neutrality. The Company connects the decarbonization needs of the maritime industry with the supply of the carbon finance market through technology ecosystem, creating a new paradigm for maritime sustainability.  

Forward Looking Statements

This announcement contains “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including, without limitation, those with respect to the objectives, plans and strategies of the Company set forth herein and those preceded by or that include the words “believe,” “expect,” “anticipate,” “future,” “will,” “intend,” “plan,” “estimate” or similar expressions, are “forward-looking statements”. Such statements include, but are not limited to risks detailed in the Company’s filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 20-F for the fiscal year ended October 31, 2024. These forward-looking statements involve a number of risks and uncertainties, which could cause the Company’s future results to differ materially from those anticipated. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. All information provided in this press release is as of the date of the publication, and the Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

 

ZAMST renews partnership with NBA Basketball Star Trae Young as Global Brand Ambassador

TOKYO, July 17, 2025 /PRNewswire/ — ZAMST, a global leader in premium sports bracing and support, proudly announces the renewal of its global brand ambassador partnership with NBA All-Star guard Trae Young of the Atlanta Hawks. This continued alliance marks a powerful milestone in a relationship that began in 2020, rooted in shared values of resilience, innovation, and peak performance.

Trae Young in action with the ZAMST A2-DX ankle brace
Trae Young in action with the ZAMST A2-DX ankle brace

“Zamst has been with me since the beginning – through every game and every step of the way. Their braces keep me protected and confident on the court, and I am honored to continue this relationship.” – Trae Young

Trae Young : Setting the standard in NBA  

The 2024–25 season marked another remarkable chapter for Young. Selected to his fourth NBA All-Star Game and finishing the season as top assist leader further cementing his status as one of the league’s premier playmakers. Widely recognized for his deep shooting range, clutch shot-making, and elite playmaking ability, Young continues to be a driving force at the point guard position.

Off the court, he is committed to mentorship and youth development, resonating with fans around the globe.

Engineered for Greatness: Trae & ZAMST

Zamst: “Trae’s exceptional performance, leadership within his team and commitment to community align perfectly with ZAMST’s mission to empower athletes to perform at their highest potential. His leadership on and off the court makes him an ideal ambassador, and we are honored to support him as he continues to inspire the next generation”

Since first teaming up with ZAMST, Young has trusted flagship A2-DX ankle braces —to maintain peak condition and protect himself during games. As a global brand ambassador, Young promotes the importance of injury prevention and proper conditioning for athletes of all levels.

Explore why Trae Young trusts the A2-DX:  https://www.youtube.com/watch?v=shqkbR7AHh0

Trae Young ankle brace and Zamst full support gear lineup
Trae Young ankle brace and Zamst full support gear lineup

ABOUT ZAMST

Zamst reinforces and protects athletes by providing premium and technical bracing products derived from innovative materials, designs and manufacturing processes. Created in 1992 by Nippon Sigmax Co., Ltd a leader in the Japanese orthopedic market, Zamst leverages its strong medical expertise to build products that maximize anatomical functionality and performance. Trusted over 30 years by elite athletes, Zamst continuously evolves to become the most authentic sports medicine and wellness brand in the industry.

The A2-DX is one of Zamst’s signature ankle braces, widely trusted by professional basketball organizations and athletes across collegiate, high school and club levels. Designed for high-impact sports, it provides strong support for the ankle without limiting mobility.

Discover more on Trae Young ankle braces and other Zamst products at: http://www.zamst.us